Measles Is Back. How Does This Affect Patients with Rheumatic Disease?

Ruth Jessen Hickman, MD, is a graduate of the Indiana University School of Medicine. She is a freelance medical and science writer living in Bloomington, Ind.

References

1. Measles (Rubeola). For Health Professionals. Centers for Disease Control and Prevention.
2. Immunizations, vaccines, and biologicals. New measles surveillance data for 2019. World Health Organization. 2019 Apr 15.
3. Measles (Rubeola). Measles cases and outbreaks. Centers for Disease Control and Prevention. 2019.
4. Measles (Rubeola). History of measles. Centers for Disease Control and Prevention.
5. McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: Summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Jun 14;62(RR-04):1–34.
6. National Center for Immunization and Respiratory Diseases. General recommendations on immunization—recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011 Jan 28;60(2):1-64.
7. Singh JA, Saag KG, Bridges SL Jr., et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2016 Jan;68(1):1–26.
8. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014 Feb;58(3):309–318.